Watch Ticker

Protara Therapeutics, Inc. Common Stock

Go to Protara Therapeutics, Inc. Common Stock Website

$3.15

0.00 (0.00%)

Live

Previous Close

$3.15

Day Range

$0 - $0

Previous Day Range

$3.085 - $3.18

Market Cap

$121.9 million USD

Day Vol.

Previous Day Vol.

154230

Currency

USD

Primary Exchange

Nasdaq

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. It...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

Protara Therapeutics announced positive interim results from its ongoing Phase 2 ADVANCED-2 trial of TARA-002, its investigational cell-based therapy, in patients with high-risk non-muscle invasive bladder cancer (NMIBC). The results showed high complete response rates and a favorable safety profile.

Related tickers: TARA.

Read Full Article

N/A - Protara Highlights Recent Updates and Anticipated 2025 Milestones

Protara Therapeutics reported positive interim results from its ADVANCED-2 trial of TARA-002 in non-muscle invasive bladder cancer (NMIBC) patients. The company also expects to begin a pivotal trial for IV Choline Chloride and report data from its STARBORN-1 trial of TARA-002 in lymphatic malformations in 2025.

Related tickers: TARA.

Read Full Article

Trending Tickers

Please sign in to view